Pancreum LLC
Module-based artificial pancreas system
This article was originally published in Start Up
Executive Summary
Pancreum LLC is creating a wearable artificial pancreas that includes two pumps and a continuous glucose monitor. The company’s plan is to continue with development and seek regulatory approval in stages that mirror the device’s unique modular configuration.
You may also be interested in...
Closing In On An Artificial Pancreas
Medtronic may be the front-runner in the race to market, but a number of medtech start-ups hope investors will find merit in their innovative technologies. Profiles of Beta-O2, Defymed, and Pancreum.
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.